Patent: 7,083,642
✉ Email this page to a colleague
Summary for Patent: 7,083,642
Title: | Delivery of therapeutic capable agents |
Abstract: | The present invention provides improved stents and other prostheses for delivering substances to vascular and other luminal and intracorporeal environments. In particular, the present invention provides for therapeutic capable agent eluting stents with minimized undesirable loss of the therapeutic capable agent during expansion of the stent. |
Inventor(s): | Sirhan; Motasim (Sunnyvale, CA), Yan; John (Los Gatos, CA) |
Assignee: | Avantec Vascular Corporation (Sunnyvale, CA) |
Application Number: | 10/206,853 |
Patent Claims: | see list of patent claims |
Details for Patent 7,083,642
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Hoffmann-la Roche Inc. | ZENAPAX | daclizumab | Injection | 103749 | 12/10/1997 | ⤷ Try a Trial | 2020-12-22 |
Biogen Inc. | ZINBRYTA | daclizumab | Injection | 761029 | 05/27/2016 | ⤷ Try a Trial | 2020-12-22 |
Biogen Inc. | ZINBRYTA | daclizumab | Injection | 761029 | 05/26/2017 | ⤷ Try a Trial | 2020-12-22 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |